# RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial

> **NCT00364689** · PHASE3 · TERMINATED · sponsor: **University of Miami** · enrollment: 13 (actual)

## Conditions studied

- Hepatic Encephalopathy

## Interventions

- **DRUG:** Rifaximin
- **DRUG:** Lactulose
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00364689
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-08
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Difficult to recruit participants
- **Last updated:** 2019-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00364689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00364689, "RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00364689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*